VPH — Valeo Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Valeo Pharma, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

	2019 October 31st	2020 October 31st	2021 October 31st	2022 October 31st	2023 October 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.335	2.84	2.04	22.5	7.5
Net Total Accounts Receivable
Net Total Receivables	0.613	1.22	1.8	5.43	6.57
Total Inventory
Prepaid Expenses
Total Current Assets	1.65	5.41	12.3	40.5	25.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.296	0.605	2.14	2.25	2.66
Net Intangible Assets
Other Long Term Assets
Total Assets	5.81	11	21	58.3	41.2
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.48	4.28	15.3	15.3	20.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.83	7.89	19	76.1	81.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.022	3.07	2.05	-17.8	-40.3
Total Liabilities & Shareholders' Equity	5.81	11	21	58.3	41.2
Total Common Shares Outstanding